Apple Posts Best Sales Growth Since 2021, Amazon's Cloud Business Lags
The Rundown
00:00
Moderna Faces Revenue Challenges and Dalio's Exit from Finance
This chapter explores the decline in Moderna's stock following a revenue forecast cut attributed to delayed COVID booster vaccine shipments. It also covers Ray Dalio's departure from Bridgewater Associates and his transition into a finance influencer, concluding with a reflection on a busy week and audience appreciation.
Transcript
Play full episode
